Published in Neurobiol Aging on January 26, 2007
Mast cells and angiogenesis in gastric carcinoma. Int J Exp Pathol (2010) 1.09
3D reconstruction of the crural and thoracolumbar fasciae. Surg Radiol Anat (2011) 0.94
Aneurysm permeability following coil embolization: packing density and coil distribution. J Neurointerv Surg (2014) 0.86
Intussusceptive microvascular growth in human glioma. Clin Exp Med (2009) 0.81
Neuroregeneration and dementia: new treatment options. J Mol Psychiatry (2013) 0.77
Spatial distribution of mast cells around vessels and glands in human gastric carcinoma. Clin Exp Med (2017) 0.75
Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature (1998) 6.27
Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons. J Pharm Pharmacol (1973) 3.54
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol (1970) 3.54
Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. Eur J Pharmacol (1969) 2.61
Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. Eur J Pharmacol (1969) 2.26
Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci (1997) 2.23
Cellular localization of monoamines in the area postrema of certain mammals. J Comp Neurol (1965) 2.13
Functional role of the nigro-neostriatal dopamine neurons. Acta Pharmacol Toxicol (Copenh) (1966) 2.13
Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmacol (1967) 2.08
[Changes in the pineal body in rats treated with clomiphene]. Boll Soc Ital Biol Sper (1971) 1.98
Localization of monoamines in the lower brain stem. Experientia (1964) 1.72
Primary paraganglioma of the thyroid gland. J Endocrinol Invest (2004) 1.68
Biochemistry, molecular biology, and physiology of the glucocorticoid receptor. Endocr Rev (1987) 1.68
Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc Natl Acad Sci U S A (1986) 1.61
Volume transmission in the CNS and its relevance for neuropsychopharmacology. Trends Pharmacol Sci (1999) 1.54
Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci U S A (2000) 1.53
Intercellular communication in the brain: wiring versus volume transmission. Neuroscience (1995) 1.50
Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons. Acta Physiol Scand (1967) 1.49
Pharmacological studies on the hypotensive effects of clonidine. Eur J Pharmacol (1971) 1.49
High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J (1992) 1.48
Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease. Neurology (2003) 1.48
Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat. Brain Res (1969) 1.47
Hypothermic effect of apomorphine in the mouse. J Pharm Pharmacol (1972) 1.43
Clinical severity of ischemic stroke and neural damage biomarkers in the acute setting: the STROke MArkers (STROMA) study. Minerva Anestesiol (2013) 1.39
Adenosine-dopamine interactions in the brain. Neuroscience (1992) 1.39
Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci U S A (1991) 1.39
Dopamine nerve terminals in the rat limbic cortex: aspects of the dopamine hypothesis of schizophrenia. Science (1974) 1.38
Effect of apomorphine on the GABA turnover in the DA cell group rich area of the mesencephalon. Evidence for the involvement of an inhibitory gabergic feedback control of the ascending DA neurons. Neurosci Lett (1975) 1.38
Demonstration and mapping of central neurons containing dopamine, noradrenaline, and 5-hydroxytryptamine and their reactions to psychopharmaca. Pharmacol Rev (1966) 1.37
Adrenergic and cholinergic nerve terminals in skeletal muscle vessels. Acta Physiol Scand (1970) 1.34
The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons. Neuropharmacology (1971) 1.33
Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci (1970) 1.33
Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology (1985) 1.32
ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors. Eur J Pharmacol (1972) 1.31
C2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transduction. Exp Cell Res (2010) 1.30
Histochemical amd biochemical effects of diethyldithiocarbamate on tissue catecholamines. J Pharm Pharmacol (1966) 1.29
On the projections from the locus coeruleus noradrealine neurons: the cerebellar innervation. Brain Res (1971) 1.29
Characterization and tissue localization of catecholamine synthesizing enzymes. Pharmacol Rev (1972) 1.27
Evidence for a new type of dopamine receptor stimulating agent. J Pharm Pharmacol (1971) 1.27
Effects of prolactin and ergot alkaloids on the tubero-infundibular dopamine (DA) neurons. Neuroendocrinology (1972) 1.27
Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry. Eur J Pharmacol (1975) 1.27
Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats. Brain Res (1972) 1.26
Mapping out of catecholamine and 5-hydroxytryptamine neurons innervating the telencephalon and diencephalon. Life Sci (1965) 1.23
The effect of some psychoactive drugs on central monoamine neurons. Eur J Pharmacol (1967) 1.23
Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. J Invest Dermatol (1999) 1.22
Ibotenic acid-induced neuronal degeneration: a morphological and neurochemical study. Exp Brain Res (1979) 1.22
The effect of immobilization stress on the activity of central monoamine neurons. Life Sci (1968) 1.22
The effect of imipramine on central 5-hydroxytryptamine neurons. J Pharm Pharmacol (1968) 1.21
Evidence for adenosine/dopamine receptor interactions: indications for heteromerization. Neuropsychopharmacology (2000) 1.20
The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain. J Neural Transm (Vienna) (2009) 1.20
Ergocornine and 2-Br-alpha-ergocryptine. Evidence for prolonged dopamine receptor stimulation. Med Biol (1974) 1.20
Gastric dysplasia. A follow-up study. Am J Gastroenterol (1993) 1.19
The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J Neurosci (1993) 1.18
Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia. Brain Res Brain Res Rev (1998) 1.18
A possible role played by central monoamine neurones in thermo-regulation. Acta Physiol Scand (1968) 1.17
The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharmacology (1999) 1.17
Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res Rev (2008) 1.15
Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide. Br J Pharmacol (1968) 1.15
Rat medulla oblongata. II. Dopaminergic, noradrenergic (A1 and A2) and adrenergic neurons, nerve fibers, and presumptive terminal processes. J Comp Neurol (1985) 1.14
Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors. J Pharm Pharmacol (1972) 1.13
The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission. Neurosci Lett (1998) 1.12
Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms. J Neural Transm (Vienna) (2006) 1.11
The emergence of the volume transmission concept. Brain Res Brain Res Rev (1998) 1.11
Mapping and computer assisted morphometry and microdensitometry of glucocorticoid receptor immunoreactive neurons and glial cells in the rat central nervous system. Neuroscience (1994) 1.11
Wiring and volume transmission in the central nervous system: the concept of closed and open synapses. Prog Neurobiol (1996) 1.11
Effect of prostaglandin E 2 on central and peripheral catecholamine neurons. Eur J Pharmacol (1973) 1.09
Further mapping of central 5-hydroxytryptamine neurons: studies with the neurotoxic dihydroxytryptamines. Adv Biochem Psychopharmacol (1974) 1.09
The dopamine D1 receptor-rich main and paracapsular intercalated nerve cell groups of the rat amygdala: relationship to the dopamine innervation. Neuroscience (2003) 1.09
Evidence for adrenaline neurons in the rat brain. Acta Physiol Scand (1973) 1.08
An unusual case of gonadic germinal tumor in a brother and sister. Cancer (1974) 1.08
Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors. Biochem Pharmacol (1999) 1.07
Neuropeptide Y in vitro selectivity increases the number of alpha 2-adrenergic binding sites in membranes of the medulla oblongata of the rat. Acta Physiol Scand (1983) 1.07
Endothelin-1 induced lesions of the frontoparietal cortex of the rat. A possible model of focal cortical ischemia. Neuroreport (1997) 1.06
Histochemical studies on the distribution of catecholamines and 5-hydroxytryptamine after intraventricular injections. Histochemie (1968) 1.06
Localization of glucocorticoid receptor mRNA in the male rat brain by in situ hybridization. Proc Natl Acad Sci U S A (1988) 1.06
DL-5-hydroxytryptophan-induced changes in central monoamine neurons after peripheral decarboxylase inhibition. J Pharm Pharmacol (1971) 1.06
Functional regeneration of 5-hydroxytryptamine nerve terminals in the rat spinal cord following 5, 6-dihydroxytryptamine induced degeneration. Brain Res (1974) 1.06
PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract. Histopathology (2005) 1.06
Production of discrete changes in dopamine and noradrenaline levels and turnover in various parts of the rat brain following exposure to xylene, ortho-, meta-, and para-xylene, and ethylbenzene. Toxicol Appl Pharmacol (1981) 1.05
Organization of choroid plexus epithelial and endothelial cell tight junctions and regulation of claudin-1, -2 and -5 expression by protein kinase C. Neuroreport (2000) 1.05
c-fos reduces corticosterone-mediated effects on neurotrophic factor expression in the rat hippocampal CA1 region. J Neurosci (2003) 1.05
Adenosine A2A agonists: a potential new type of atypical antipsychotic. Neuropsychopharmacology (1997) 1.04
Prominent expression of acidic fibroblast growth factor in motor and sensory neurons. Neuron (1991) 1.04
Cardiovascular effects of morphine and opioid peptides following intracisternal administration in chloralose-anesthetized rats. Eur J Pharmacol (1978) 1.04
Histochemical studies on the effect of (positive)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-hydroxytryptamine. Eur J Pharmacol (1968) 1.04
Changes in dialysate concentrations of glutamate and GABA in the brain: an index of volume transmission mediated actions? J Neurochem (2003) 1.04